home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

344 rows where filing_period = "third_quarter", filing_year = 2021 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • MED · 344 ✖

filing_year 1

  • 2021 · 344 ✖

filing_period 1

  • third_quarter · 344 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2674805 BALLARD PARTNERS c9a323fd-d81d-4ff8-a00e-3d0650937414 3T BALLARD PARTNERS 401104288 ORIGIN LOGISTICS, LLC 2021 third_quarter MED Issues related to diagnostic testing for COVID-19.   60000   0 1 2021-09-15T17:15:15.373000-04:00
2675557 WINNING STRATEGIES WASHINGTON 833661bd-94cc-4e9f-bd9a-f5a8be2eee27 3T WINNING STRATEGIES WASHINGTON 50796 PHLOW CORPORATION 2021 third_quarter MED Domestic manufacturing of essential generic medicines; supply chain disruptions and shortages of foreign-manufactured medicines HOUSE OF REPRESENTATIVES,SENATE 30000   0 1 2021-09-29T17:39:10.693000-04:00
2675587 THE CONSILIO GROUP 999d73e1-cc52-4c27-b74b-4ec448901043 Q3 THE CONSILIO GROUP 400374717 DETECTACHEM 2021 third_quarter MED Chemical detection test for COVID-19 Air Force, Dept of,Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Education, Dept of,Federal Bureau of Investigation (FBI),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,Transportation Security Administration (TSA),White House Office 16500   0 0 2021-09-30T12:58:23.870000-04:00
2675655 FRANCIS EDWARD & CRONIN, INC. c3263745-22ed-485e-9c2e-14e6e42a156c Q3 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2021 third_quarter MED Issues and legislation related to Alzheimer's disease research Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE 20000   0 0 2021-10-01T08:59:50.457000-04:00
2675656 FRANCIS EDWARD & CRONIN, INC. 70a6c1fa-3ec5-4185-bbea-e37dabd05f8b Q3 FRANCIS EDWARD & CRONIN, INC. 311314 PATH DECISION SUPPORT SOFTWARE, LLC 2021 third_quarter MED Issues and legislation related to diabetes treatment and diagnosis HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,Veterans Affairs, Dept of (VA)     0 0 2021-10-01T09:03:51.083000-04:00
2675675 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) bba68268-0f76-48b2-bf53-ab212f79d17a Q3 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 PPLA 2021 third_quarter MED Pharmaceutical Labeling Food & Drug Administration (FDA) 18700   0 0 2021-10-01T10:24:59.180000-04:00
2675918 MARSHALL BRACHMAN 4c5b1c55-b8c0-48a9-87a8-a71f9ed9b00d Q3 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2021 third_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2021-10-02T15:30:25.937000-04:00
2675960 RAY C CULVER III c156ad59-b7c2-4a3e-a731-91a9fb1bd594 Q3 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2021 third_quarter MED FY2022 Agricultural Appropriations bill funding for USDA ARS human nutrition research centers HOUSE OF REPRESENTATIVES,SENATE 5000   0 0 2021-10-03T01:48:38.950000-04:00
2676067 AMERICAN COLLEGE OF CLINICAL PHARMACY c75f644f-7937-43e1-a672-d9019562331a Q3 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2021 third_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2021-10-04T10:02:17.787000-04:00
2676139 THE HARRIS FIRM cf4fa00c-fa8a-4c60-bde9-dc736db38e14 Q3 THE HARRIS FIRM 68376 HOLISTIC INDUSTRIES INC. 2021 third_quarter MED Issues pertaining to cannabis CSA scheduling. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-04T12:10:52.667000-04:00
2676193 MAGILL ASSOCIATES, LLC c654b1f4-e206-4cbf-b22b-a619b35f3d14 Q3 MAGILL ASSOCIATES, LLC 401103511 THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES 2021 third_quarter MED FY'22 defense appropriations bill for the development of a synthetic vaccine Army, Dept of (Other),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-10-04T14:52:14.787000-04:00
2676396 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 8dd62ee0-f712-43eb-a87d-aa36d3f2c6b5 Q3 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 1466 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 2021 third_quarter MED AACC joined with other healthcare groups in writing to the Centers for Medicare and Medicaid Services requesting the agency issue a State Medicaid Director Letter that instructs State Medicaid programs to recognize and process claims submitted with Proprietary Laboratory Analysis (PLA) codes established by the American Medical Associations Current Procedural Terminology (CPT) Editorial Panel. AACC joined with other healthcare groups in writing to the Centers for Medicare and Medicaid Services to express concerns regarding coding changes included in both the 2021 National Correct Coding Initiative (NCCI) Policy Manual for Medicare Services and the 2021 NCCI Policy Manual for Medicaid Services, which took effect January 1, 2021. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2021-10-05T12:23:59.750000-04:00
2676418 BEN BARNES GROUP LP 52fb3470-0877-4938-bc77-e764d5adb1d6 Q3 BEN BARNES GROUP LP 5415 ENVIGO RMS LLC 2021 third_quarter MED Medical/Disease Research HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2021-10-05T14:23:10.680000-04:00
2676439 BEN BARNES GROUP LP 331aecad-1805-4926-82f9-06de314978f4 Q3 BEN BARNES GROUP LP 5415 HUNTSMAN CORPORATION 2021 third_quarter MED CMS Medicare SENATE 18750   0 0 2021-10-05T14:48:18.557000-04:00
2676978 RYAN COSTELLO STRATEGIES 9266fa94-b01b-4c2d-aa2c-114b71092cee Q3 RYAN COSTELLO STRATEGIES 401105569 CARDIOL THERAPEUTICS 2021 third_quarter MED No specific lobbying issues this quarter. HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2021-10-07T13:17:37.797000-04:00
2676982 WAKE FOREST UNIVERSITY HEALTH SCIENCES bc1ff1e2-5c48-47b5-99bb-239b3e5ac423 Q3 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2021 third_quarter MED Proposed provisions in the draft Build Back Better bill regarding mental health and maternity expanded coverage;340 (b) program guidelines; HRSA community project funding; "Research Investment to Spark the Economy" (RISE) Act; "US Citizenship Act of 2021"; Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   150000 0 0 2021-10-07T13:26:47.373000-04:00
2676998 REPUBLIC CONSULTING, LLC 3625bf38-b6f0-40b5-b6b7-00866b8bb143 Q3 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2021 third_quarter MED Monitored health Data Policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-07T13:59:53.117000-04:00
2677322 EFB ADVOCACY, LLC b2b630de-7786-4567-95e5-cc47dec820e6 Q3 EFB ADVOCACY, LLC 401104430 UNITED FOR MEDICAL RESEARCH 2021 third_quarter MED Funding Issues Related to the National Institutes of Health HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-10-08T11:49:40.977000-04:00
2677420 MARSHFIELD CLINIC HEALTH SYSTEM cd8610df-7996-4b81-949d-488eb06caa81 Q3 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2021 third_quarter MED COVID-19, agricultural occupational health, NIOSH Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2021-10-08T14:58:30.160000-04:00
2677940 IMPACT MANAGEMENT GROUP 3bc80c27-3f77-49a2-aeb1-715a8fad9da5 Q3 IMPACT MANAGEMENT GROUP 401104137 ARKANSAS RESEARCH ALLIANCE 2021 third_quarter MED On behalf of client support continued and future funding for clinical research programs in Arkansas HOUSE OF REPRESENTATIVES,SENATE 9000   0 0 2021-10-11T15:03:13.240000-04:00
2678205 THE CJR GROUP, INC. e56b7c53-4429-4fe2-94ca-582e68c962ef Q3 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2021 third_quarter MED Issues related to COVID-19 and funding for hospitals HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-10-12T09:12:13.797000-04:00
2678772 ALEXANDER, BOROVICKA & O'SHEA GOVERNMENT SOLUTIONS (FKA ALEXANDER & BOROVICKA GO 76d518ce-ec1f-4b22-ba84-410808485e03 Q3 ALEXANDER, BOROVICKA & O'SHEA GOVERNMENT SOLUTIONS (FKA ALEXANDER & BOROVICKA GO 40025213 VOLAN TECHNOLOGY INC. 2021 third_quarter MED Discuss COVID-19 technology and detection for indoor spaces and uses. SENATE     0 0 2021-10-12T16:05:05.423000-04:00
2678785 STANFORD UNIVERSITY 0049d40e-d6de-4b83-b42b-731412f5c7a6 Q3 STANFORD UNIVERSITY 36492 STANFORD UNIVERSITY 2021 third_quarter MED H.R.708; S168 Temporary Reciprocity to Ensure Access to Treatment Act H.R. 2256, S. 834 Resident Physician Shortage Reduction Act of 2021 Title VII HRSA Health Professions Programs Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2021-10-12T16:06:06.760000-04:00
2678834 MCDERMOTT+ LLC 936f6802-fe4a-4fc0-983b-706b2ee99c14 Q3 MCDERMOTT+ LLC 401103287 COALITION FOR 21ST CENTURY MEDICINE 2021 third_quarter MED Issues concerning regulation of laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 40000   0 0 2021-10-12T17:04:17.710000-04:00
2678851 WASHINGTON STATE UNIVERSITY 711d9f3f-964b-45d9-bef7-84de0c542660 Q3 WASHINGTON STATE UNIVERSITY 40657 WASHINGTON STATE UNIVERSITY 2021 third_quarter MED Disease Surveilance, CLIA, Public Health Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Environmental Protection Agency (EPA),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Transportation, Dept of (DOT),White House Office   72053 0 0 2021-10-12T17:21:20.233000-04:00
2678996 COMPASS MANAGEMENT PARTNERS, INC. c4d75172-0734-4b8a-b9e7-110a3e09c931 Q3 COMPASS MANAGEMENT PARTNERS, INC. 401105171 THE LIVING LEGACY FOUNDATION OF MARYLAND 2021 third_quarter MED Regulations impacting accountability requirements at organ procurement organizations; organ donation matters       0 0 2021-10-13T10:16:06.507000-04:00
2679061 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 91ecd51b-b909-4a12-84bc-21a4a792125f Q3 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 401103161 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 2021 third_quarter MED H.R. 3684 - Infrastructure Investment & Jobs Act HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2021-10-13T10:47:22.387000-04:00
2679104 COVINGTON & BURLING LLP a11ad9d4-3d9a-48d5-a9bf-727ea4247f36 Q3 COVINGTON & BURLING LLP 11195 SL 2T, LLC ("SMARTLABS") 2021 third_quarter MED Education and support for policies and funding to advance turnkey, co-located, on-demand pharma grade research laboratory environments. HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2021-10-13T11:11:37.840000-04:00
2679118 COVINGTON & BURLING LLP fd354bc2-88c1-4823-ae97-86843c3591df 3T COVINGTON & BURLING LLP 11195 ZYMERGEN INC. 2021 third_quarter MED Enhanced investment in biomanufacturing; investment in workforce development, infrastructure, and R&D for synthetic biology; shoring up manufacturing supply chains for critical pharmaceutical ingredients; supporting government investment in mRNA-based technologies   20000   0 1 2021-10-13T11:16:41.003000-04:00
2679214 ISEMAN & ASSOCIATES LLC 2528ad86-fe3b-4a85-8fde-6c9077a3a12c Q3 ISEMAN & ASSOCIATES LLC 401103582 TICHENOR VENTURES, LLC 2021 third_quarter MED Monitoring biotech legislation HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-10-13T12:03:07.827000-04:00
2679272 HELIX, INC. 449eb306-2c9c-4e91-bd65-3c3adbc033b7 Q3 HELIX, INC. 401106164 HELIX, INC. 2021 third_quarter MED genomic research and testing, COVID-19 testing and research Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   36000 0 0 2021-10-13T13:23:24.617000-04:00
2679524 GOVERNMENT COUNSEL, LLC d15fcb36-a883-4e71-953a-9f4e847e2668 Q3 GOVERNMENT COUNSEL, LLC 401105070 HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) 2021 third_quarter MED Verifying Accurate Leading-edge IVCT Development (VALID) Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-10-13T15:57:40.093000-04:00
2679533 AMERICAN ACADEMY OF PHYSICAL MEDICINE AND REHABILITATION e6ae46d6-ef1b-4e33-93f5-03b96b75a8a3 Q3 AMERICAN ACADEMY OF PHYSICAL MEDICINE AND REHABILITATION 400864533 AMERICAN ACADEMY OF PHYSICAL MEDICINE AND REHABILITATION 2021 third_quarter MED Rehabilitation research funding Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   10000 0 0 2021-10-13T15:57:41.443000-04:00
2679617 AMERICAN ASSOCIATION FOR CANCER RESEARCH 835b16d2-8e04-483c-a6da-e2b2b2f6702f Q3 AMERICAN ASSOCIATION FOR CANCER RESEARCH 400601833 AMERICAN ASSOCIATION FOR CANCER RESEARCH 2021 third_quarter MED Cancer research Oncology product review at the FDA Pediatric research and cancer care Clinical trials HOUSE OF REPRESENTATIVES,SENATE   100000 0 0 2021-10-13T17:07:04.520000-04:00
2679749 MANATOS & MANATOS e668b733-c79c-4a36-aad0-30850d3bbfc5 Q3 MANATOS & MANATOS 23634 BARBARA ANN KARMANOS CANCER INSTITUTE 2021 third_quarter MED PPS-exemption HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-10-14T08:14:43.323000-04:00
2679762 MOLNLYCKE HEALTH CARE US, LLC d24a8690-db19-4b53-9087-5987200ebf94 Q3 MOLNLYCKE HEALTH CARE US, LLC 401104898 MOLNLYCKE HEALTH CARE US, LLC 2021 third_quarter MED Report language to support reduction of pressure injuries, falls, and infections HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2021-10-14T08:40:48.297000-04:00
2680133 MCHUGH LEMAY ASSOC., LLC e375e9c5-f855-4974-b57c-334eaed40680 Q3 MCHUGH LEMAY ASSOC., LLC 401105253 CLARK STREET ASSOCIATES LLC ON BEHALF OF QORVO 2021 third_quarter MED Issues related to COVID testing - no specific legislation. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-10-14T11:55:10.173000-04:00
2680754 BOLD STRATEGIES, LLC 881fef2a-8b15-4f3c-950d-6151ead7c121 Q3 BOLD STRATEGIES, LLC 401104653 PENNINGTON BIOMEDICAL RESEARCH CENTER 2021 third_quarter MED Obesity and COVID research. FY22 appropriations. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-10-14T17:06:01.650000-04:00
2680760 BOLD STRATEGIES, LLC d3635fe4-ffec-4374-b898-82b8d103a565 Q3 BOLD STRATEGIES, LLC 401104653 COUHIG PARTNERS LLC 2021 third_quarter MED COVID related and other medical research. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-10-14T17:08:03.357000-04:00
2680811 NATURAL RESOURCE RESULTS LLC d4319957-3f32-41b2-8b2e-074e098b001d Q3 NATURAL RESOURCE RESULTS LLC 321555 SHINE MEDICAL TECHNOLOGIES 2021 third_quarter MED Support funding at NNSA for Moly-99 domestic production facility construction. SENATE 30000   0 0 2021-10-14T17:39:18.520000-04:00
2680881 FOLEY & LARDNER LLP 750e1dbc-cfac-4289-b968-f84b7348aa43 Q3 FOLEY & LARDNER LLP 15042 CARDIAC RMS 2021 third_quarter MED Remote Cardiac Monitoring HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2021-10-14T20:32:45.297000-04:00
2681150 SQUIRE PATTON BOGGS aba9ade5-2191-4cce-bff1-e35954a581ac Q3 SQUIRE PATTON BOGGS 30906 LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC. 2021 third_quarter MED Funding support for federally qualified health centers; reauthorization of programs HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-10-15T10:19:08.817000-04:00
2681213 TODD STRATEGY GROUP 8599bacd-2037-4e35-be20-34f9cb548eff Q3 TODD STRATEGY GROUP 401103321 ORGANIZE.ORG 2021 third_quarter MED Organ procurement policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-10-15T10:41:27.233000-04:00
2681257 UNIVERSITY OF IOWA e54be645-16c7-4735-89a7-a846cbb561ec Q3 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2021 third_quarter MED Support for robust funding for federal agencies that fund medical and disease research Support for increased federal funding for research and response efforts in response to COVID-19 Agriculture, Dept of (USDA),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE   60000 0 0 2021-10-15T10:46:32.843000-04:00
2681286 DREXEL UNIVERSITY 581a445e-814f-4b2f-8dba-cdb00e15b0c6 Q3 DREXEL UNIVERSITY 40032273 DREXEL UNIVERSITY 2021 third_quarter MED Research, education and other matters related to higher ed. HOUSE OF REPRESENTATIVES,SENATE   81000 0 0 2021-10-15T10:52:40.443000-04:00
2681484 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 169df1f1-0e58-410d-bdb2-bbe86c75c22a Q3 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 312496 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 2021 third_quarter MED CHGME, NIH, PACT ACT, Genomics, Cures 2.0 Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office   31485 0 0 2021-10-15T12:07:40.287000-04:00
2681551 KOUNTOUPES DENHAM CARR & REID, LLC d4cb41e2-3517-44e1-892a-d28c62b74b84 Q3 KOUNTOUPES DENHAM CARR & REID, LLC 320918 ICI (INFRARED CAMERAS, INC.) 2021 third_quarter MED Issues relating to bio-risk detection and mitigation using infrared thermal imaging technology. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-15T12:35:58.210000-04:00
2681666 INFECTIOUS DISEASES SOCIETY OF AMERICA ccf32174-7e65-4286-bf94-74a5218a8526 Q3 INFECTIOUS DISEASES SOCIETY OF AMERICA 54836 INFECTIOUS DISEASES SOCIETY OF AMERICA 2021 third_quarter MED Antimicrobial resistance research, infectious disease product R&D regulatory science, unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; support for evidence-based decision making; point-of-care diagnostic tests; and organ transplant policies to allow HIV+ to HIV+ organ transplants, Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR Act-S. 2076/H.R. 3932), Verifying Accurate Leading Edge IVCT Development (S. 2209/HR. 4128) Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   77000 0 0 2021-10-15T13:56:21.877000-04:00
2681964 GREENBERG TRAURIG, LLP ac9135ec-f406-4f71-9208-dc0fc7d181df Q3 GREENBERG TRAURIG, LLP 16896 LIFE MOLECULAR IMAGING (F/K/A PIRAMAL IMAGING LIMITED) 2021 third_quarter MED Administrative and legislative monitoring and outreach related to Alzheimers Disease research funding. Administrative and legislative monitoring and outreach related to pass-through payments for clinical trials. Draft Revision, Medicare Diagnostic Radiopharmaceutical Payment Equity Act. H.R. 4479, Facilitating Innovative Nuclear Diagnostics Act of 2021. S. 2609, Facilitating Innovative Nuclear Diagnostics Act of 2021. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES 20000   0 0 2021-10-15T15:44:26.697000-04:00
2682164 BLUEBIRD STRATEGIES 167cb505-6134-4582-a965-74f5bc997ca6 Q3 BLUEBIRD STRATEGIES 401105447 MYRIAD GENETICS, INC. 2021 third_quarter MED Legislation to regulate clinical labs under CLIA and FDA. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-10-15T17:08:12.020000-04:00
2682174 BLUEBIRD STRATEGIES de8b1d9f-f542-4d90-b759-dc5c69169465 Q3 BLUEBIRD STRATEGIES 401105447 GLOBAL DOWN SYNDROME FOUNDATION 2021 third_quarter MED Funding for Immune Facility at Crnic Institute FY22 LHHS Appropriations. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2021-10-15T17:12:14.217000-04:00
2682203 BLUEBIRD STRATEGIES 90cb8cc6-3108-47a4-ad13-17affb0751d2 Q3 BLUEBIRD STRATEGIES 401105447 MYOTONIC 2021 third_quarter MED Increasing funding for Myotonic Dystrophy research. Fiscal Year 2020 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. Myotonic Dystrophy resolution. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2021-10-15T17:26:21.050000-04:00
2682275 FORBES-TATE 15ae2d3b-9eae-49e4-80f8-4826b8253b3a Q3 FORBES-TATE 400976792 AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION 2021 third_quarter MED Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-15T19:27:41.393000-04:00
2682339 TIBER CREEK GROUP c87c8610-beb4-4dc3-b4d8-1bf23846edff Q3 TIBER CREEK GROUP 20744 JAZZ PHARMACEUTICALS 2021 third_quarter MED Issues related to the FDA and S. 3032 - the FDA STATES Act (115th Congress), and Health and Human Services pertaining to CBD policies. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-15T21:03:59.633000-04:00
2682396 FORBES-TATE b2da4e83-96a3-4b6e-b938-85bef883026f Q3 FORBES-TATE 400976792 COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION 2021 third_quarter MED Issues pertaining to government-wide federal regulation of cannabis. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-10-15T22:24:10.047000-04:00
2682559 MARSHALL & POPP, LLC 3be130e4-ba5b-4e81-bfaa-e63b0107e3c2 Q3 MARSHALL & POPP, LLC 401105121 BUTTERFLY NETWORK, INC. 2021 third_quarter MED Issues related to medical device manufacturing / insurance / technology. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-10-16T08:58:29.997000-04:00
2682621 FORBES-TATE 3ddc2746-c2e6-424a-9558-378fe35b0d22 Q3 FORBES-TATE 400976792 CSL BEHRING 2021 third_quarter MED Issues related to COVID-19 response efforts. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-16T09:59:50.880000-04:00
2682651 IMPACT HEALTH POLICY PARTNERS 1e9293a0-5592-4e33-98ab-46321d38772d Q3 IMPACT HEALTH POLICY PARTNERS 401104696 ABBOTT LABORATORIES 2021 third_quarter MED Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-10-16T10:37:03.620000-04:00
2682653 IMPACT HEALTH POLICY PARTNERS ea39f97b-9339-4ea0-be98-d51a99e11d72 Q3 IMPACT HEALTH POLICY PARTNERS 401104696 CHILDREN'S HOSPITAL COLORADO 2021 third_quarter MED Issues related to pediatric research and children's hospital graduate medical education. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-10-16T10:41:04.650000-04:00
2682662 K&L GATES, LLP bddae1a9-a4cd-47a1-a69a-c850ad47bacb Q3 K&L GATES, LLP 32098 CHEMBIO DIAGNOSTICS, INC. 2021 third_quarter MED Issues related to disease diagnostics testing and manufacturing - no specific legislation. SENATE 10000   0 0 2021-10-16T10:48:08.647000-04:00
2682665 IMPACT HEALTH POLICY PARTNERS 3ba170e3-5c06-43a5-89d2-a388bf2938e9 Q3 IMPACT HEALTH POLICY PARTNERS 401104696 HACKENSACK MERIDIAN HEALTH 2021 third_quarter MED Issues related to research funding, NIH and other matters. HOUSE OF REPRESENTATIVES,SENATE,White House Office 30000   0 0 2021-10-16T10:52:09.607000-04:00
2683064 MS. TAMI WAHL 3aaf88d3-23aa-4a50-9337-56a91b656765 Q3 MS. TAMI WAHL 401104405 ASSOCIATION OF CANNABIS SPECIALISTS 2021 third_quarter MED Ensuring a medical cannabis paradigm is included in any comprehensive federal reform legislation and that such paradigm is subject to appropriate standards to allow best possible patient outcomes. SENATE     0 0 2021-10-16T16:33:03.790000-04:00
2683146 CAPITOL COUNSEL LLC e2e6dda6-3191-48fd-95c7-d993dd4cd8ec Q3 CAPITOL COUNSEL LLC 313715 BLUE EARTH DIAGNOSTICS, INC. 2021 third_quarter MED To gain support for adequate Medicare reimbursement for diagnostic radiopharmaceuticals; Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-10-16T19:10:25.087000-04:00
2683159 CAPITOL COUNSEL LLC 504e615d-c9be-44d7-b953-aa6a7638a7d3 Q3 CAPITOL COUNSEL LLC 313715 EMD SERONO, INC. 2021 third_quarter MED Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-16T19:53:30.727000-04:00
2683168 CAPITOL COUNSEL LLC 7b01fc93-7f26-41e4-b0d7-d4ee8213467b Q3 CAPITOL COUNSEL LLC 313715 MASSACHUSETTS BIOTECHNOLOGY COUNCIL 2021 third_quarter MED Monitor health and tax legislation pertaining to the biotechnology industry. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-10-16T20:07:33.077000-04:00
2683302 FORBES-TATE 258482f6-41fe-4c07-9fbe-2f954047101b Q3 FORBES-TATE 400976792 LUNDBECK LLC 2021 third_quarter MED Issues related to Mental health and Alzheimer's disease research; Issues related to the Food and Drug Administration; Issues related to protected class drug. Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-10-17T13:38:24.463000-04:00
2683312 HAWLEY LLC e8964242-8f13-43a8-8302-d8a827fc828b Q3 HAWLEY LLC 401105460 MLA ASSOCIATES ON BEHALF OF CLARK STREET ASSOCIATES LLC ON BEHALF OF QORVO 2021 third_quarter MED Issues related to pathogen testing for COVID 19 and other diseases. Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-10-17T13:44:26.823000-04:00
2683335 FORBES-TATE dafa60cc-9e76-4de9-8ef9-c2b5cebab4ae 3T FORBES-TATE 400976792 NASH ALLIANCE COALITION 2021 third_quarter MED Issues related to the NASH Care Act - preventing, diagnosing, and treating nonalcoholic steatohepatitis. HOUSE OF REPRESENTATIVES,SENATE     0 1 2021-10-17T14:15:33.863000-04:00
2683433 LYMPHOMA RESEARCH FOUNDATION 1d7e5a8f-fb45-43b8-bd27-e4703d14438c Q3 LYMPHOMA RESEARCH FOUNDATION 300696 LYMPHOMA RESEARCH FOUNDATION 2021 third_quarter MED Advanced Research Projects Agency for Health (ARPA-H) HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-10-17T15:36:55.333000-04:00
2683441 TURNER & GOSS LLP 0d67d2d8-ba36-4f13-aeb7-e805133b3b8b Q3 TURNER & GOSS LLP 316310 LYMPHOMA RESEARCH FOUNDATION 2021 third_quarter MED Advice on the structure and financing of the Advanced Research Projects Agency for Health (ARPA-H). HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-10-17T15:47:59.277000-04:00
2683445 TURNER & GOSS LLP f2897215-36f7-41ae-911b-04271855a011 Q3 TURNER & GOSS LLP 316310 CANCER LEADERSHIP COUNCIL 2021 third_quarter MED Provide advice on the organizational structure and mission of the Advanced Research Project Agency for Health (ARPA-H). HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-10-17T15:59:01.517000-04:00
2683728 MICHIGAN TECHNOLOGICAL UNIVERSITY 2c1ec3af-e3c7-4b00-b730-d6e38ed61f04 Q3 MICHIGAN TECHNOLOGICAL UNIVERSITY 25181 MICHIGAN TECHNOLOGICAL UNIVERSITY 2021 third_quarter MED Discussed issues of interest related to higher education for the COVID-19 pandemic. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2021-10-18T08:19:09.477000-04:00
2683796 SAM ACTION, INC. 06069724-cb8d-48a8-8d48-2594b9f09fa4 Q3 SAM ACTION, INC. 401104337 SAM ACTION, INC. 2021 third_quarter MED H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marijuana Research Expansion Act, to lower the barriers of researching marijuana. Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),Office of Natl Drug Control Policy (NDCP),SENATE,Small Business Administration (SBA),White House Office   10000 0 0 2021-10-18T09:03:22.190000-04:00
2684057 DQB INTERNATIONAL 4af058ac-e66c-4b83-a55a-3c0f35572f99 Q3 DQB INTERNATIONAL 291834 TEXAS BIOMEDICAL RESEARCH INSTITUTE 2021 third_quarter MED FY 2022 Labor, HHS Appropriations Bill HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-10-18T10:09:26.767000-04:00
2684205 WATKINS & EAGER PLLC d6c2ecbd-899a-44c0-b533-5799a49582e5 Q3 WATKINS & EAGER PLLC 401104403 NATIONAL FRAGILE X FOUNDATION 2021 third_quarter MED Encourage Members to act favorably on legislation that would benefit those impacted by Fragile X & their constituents. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2021-10-18T10:47:06-04:00
2684275 THE PRENDA GROUP LLC 5f497fe4-e697-4ccb-b3df-9e5b054d91be Q3 THE PRENDA GROUP LLC 401104543 UV-CONCEPTS 2021 third_quarter MED Emergency response to COVID-19 Pandemic. Assistance to Hospitals / Veterans Administration Facilities / First Responders / Medical facilities etc. for patients, visitors, and healthcare workers. ULTRAVIOLET LIGHT ENCLOSURE TECHNOLOGY FOR BROAD APPLICATIONS IN HEALTHCARE AND NON-HEALTHCARE SECTORS. Monitoring COVID-19 Stimulus Packages and appropriations. Coronavirus Response and Relief HR 3684 Monitoring Infrastructure. Veterans Appropriations HR 4355. HR 4550 Transportation Appropriations HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-10-18T10:57:50-04:00
2684352 SQUIRE PATTON BOGGS 7f606d7c-7fe1-493b-ab3f-2c94eb7a1f9c Q3 SQUIRE PATTON BOGGS 30906 ALLIANCE FOR BIOSECURITY 2021 third_quarter MED Preparedness and response as it relates to Biosecurity. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2021-10-18T11:17:43-04:00
2684600 FORBES-TATE 401211ab-d31e-42f4-8767-4d2d7bc92f9e Q3 FORBES-TATE 400976792 AMGEN USA, INC. 2021 third_quarter MED Issues related to Biosimilars. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-18T11:54:44.293000-04:00
2684768 SQUIRE PATTON BOGGS 7e1a46e9-4165-4fd6-9843-aba2c4047686 Q3 SQUIRE PATTON BOGGS 30906 IMPACT JOURNALS, LLC 2021 third_quarter MED National Library of Medicine indexing matters. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-18T12:19:31.320000-04:00
2684821 FORBES-TATE 644c826f-f452-4042-8235-dde0167ed442 Q3 FORBES-TATE 400976792 CALIFORNIA LIFE SCIENCES ASSOCIATION 2021 third_quarter MED Issues related to the life sciences industry; Issues related to drug pricing and international reference pricing. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-18T12:26:40.670000-04:00
2684984 MEEKS, BUTERA & ISRAEL PLLC 9b28a40c-07a7-44a6-bc4f-dddc2598875d 3T MEEKS, BUTERA & ISRAEL PLLC 401105818 SOCIETY FOR BRAIN MAPPING & THERAPEUTICS (SBMT) 2021 third_quarter MED Brain technology and medical research issues and programs. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2021-10-18T13:14:25.343000-04:00
2685034 AMERICAN SOCIETY OF ADDICTION MEDICINE d1c2b6be-38ca-4cf5-813e-0fb1763e8153 Q3 AMERICAN SOCIETY OF ADDICTION MEDICINE 401104864 AMERICAN SOCIETY OF ADDICTION MEDICINE 2021 third_quarter MED Advocated for Increased appropriations for HRSAs Substance Use Disorder Treatment and Recovery Loan Repayment Program. This program provides student loan repayment for addiction treatment professionals who commit to working in underserved or high-risk communities. Advocated for increased appropriations for HRSAs Addiction Medicine Fellowship Program. This Program provides grants to institutions with training opportunities for fellows in addiction medicine and addiction psychiatry who have demonstrated interest in providing addiction treatment in underserved communities Advocated for increased appropriations for HRSAs Integrated Substance Use Disorder Training Program. This program provides grants to expand the number of nurse practitioners, physician assistants, psychologists, and social workers trained to provide addiction and mental health services in underserved community-based settings that integrate primary care, mental health, and addiction services. Advocated for increased appropriations for federal initiatives that lead to a more diverse addiction treatment workforce, such as scholarships and loan repayment targeting underrepresented minority addiction medicine professionals, including SAMHSAs Minority Fellowship Program. Advocated for the alignment of coverage and payment policies in Medicare and Medicaid with evidence-based and nationally recognized addiction treatment and placement criteria and standards (e.g., The ASAM Criteria). This would include permanent modification to the Institutions for Mental Diseases (IMD) exclusion to allow federal Medicaid funds to serve individuals with SUDs in those residential and inpatient settings that are able to demonstrate that patient assessments, clinical services, level-of-care and length-of-stay recommendations are consistent with The ASAM Criteria and that evidence based medication management using Food and Drug Administration (FDA)-approved medications are available to patients in such settings Advocated for regulatory/sub-regulatory/application guidan… Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   70000 0 0 2021-10-18T13:28:40.217000-04:00
2685417 STRATEGIC MARKETING INNOVATIONS a600c859-61cf-4a8a-8167-8d303589d103 Q3 STRATEGIC MARKETING INNOVATIONS 60550 IGM BIOSCIENCES, INC. 2021 third_quarter MED Antibody therapy for COVID-19 HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-10-18T14:35:10.333000-04:00
2685583 THE LIVINGSTON GROUP, LLC f6eb3d3d-7c61-4951-9825-c974f42d40a1 Q3 THE LIVINGSTON GROUP, LLC 49635 INNOVATIVE VACCINE TECHNOLOGIES 2021 third_quarter MED H.R.4432 S.___ FY 2022 Defense Appropriations Bill FY 2022 appropriations for the development of a synthetic vaccine Army, Dept of (Other),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-10-18T14:44:35.573000-04:00
2685700 SQUIRE PATTON BOGGS ff2a9ffd-a011-4222-87c3-ee50401e824c Q3 SQUIRE PATTON BOGGS 30906 NATIONAL CANNABIS ROUNDTABLE 2021 third_quarter MED Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2021-10-18T14:54:59.027000-04:00
2686006 UNIVERSITY OF ROCHESTER 65b87269-ad3f-4b29-ab7a-2551586f1404 Q3 UNIVERSITY OF ROCHESTER 301937 UNIVERSITY OF ROCHESTER 2021 third_quarter MED P.L. 114-255 - 21st Century Cures Act HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2021-10-18T15:26:07.690000-04:00
2686410 SUSAN B ANTHONY LIST aeae88ed-97c3-4d77-9625-a2d2fed5ecb5 Q3 SUSAN B ANTHONY LIST 400935704 SUSAN B ANTHONY LIST 2021 third_quarter MED H.R. 554, S. 78 Support and Value Moms and Babies Act; Maternal mortality; Bioethics Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   230000 0 0 2021-10-18T16:13:33.260000-04:00
2686426 WINNING STRATEGIES WASHINGTON d8dcfd5f-85c1-429e-a733-e31662103005 Q3 WINNING STRATEGIES WASHINGTON 50796 DIABETES PATIENT ADVOCACY COALITION 2021 third_quarter MED Issues related to treatment of diabetes and support for diabetes patients HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-10-18T16:14:34.797000-04:00
2686528 SMITHS GROUP SERVICES CORPORATION 4fef0021-a697-4f89-bed3-58762fb26533 Q3 SMITHS GROUP SERVICES CORPORATION 290137 SMITHS GROUP SERVICES CORPORATION 2021 third_quarter MED Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136); S.987, CARA 3.0 Act of 2021; S.586/H.R.3259, NOPAIN Act. Army, Dept of (Other),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,Transportation Security Administration (TSA),U.S. Customs & Border Protection,White House Office   250000 0 0 2021-10-18T16:27:59.477000-04:00
2686622 SIDLEY AUSTIN LLP 42e0a72a-7f54-4ac1-bdd2-9086261228b0 Q3 SIDLEY AUSTIN LLP 35230 CORD BLOOD ASSOCIATION 2021 third_quarter MED Legislative and Federal agency activities related to the Stem Cell Therapeutic and Research Reauthorization Act of 2015. Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),White House Office 20000   0 0 2021-10-18T16:43:22.260000-04:00
2686661 WINNING STRATEGIES WASHINGTON c3643eaf-80f8-4b5f-979d-a16ba9f6479c Q3 WINNING STRATEGIES WASHINGTON 50796 I AM ALS 2021 third_quarter MED Funding for ALS research in annual Defense and Labor-HHS-Education Appropriations bills Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2021-10-18T16:50:31.563000-04:00
2687174 BROWNSTEIN HYATT FARBER SCHRECK, LLP aba36892-d5a6-448b-9e44-eb45aa4159cf Q3 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 ANTHEM, INC. 2021 third_quarter MED Issues related to the individual marketplace Health insurance tax and general tax issues Part D HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-18T20:37:36.590000-04:00
2687285 KNIGHT CAPITOL CONSULTANTS 60b001f2-d0e0-4948-8e1e-76d1da4a3272 Q3 KNIGHT CAPITOL CONSULTANTS 40036301 PERSPECTUM 2021 third_quarter MED Food and Drug Administration regulation of medical devices, including Emergency Use Authorizations for critical products during the COVID-19 crisis. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2021-10-18T21:36:01.343000-04:00
2687802 OKLAHOMA STATE UNIVERSITY 1e4f2176-5656-42f9-9c11-773c6416c9e3 Q3 OKLAHOMA STATE UNIVERSITY 30165 OKLAHOMA STATE UNIVERSITY 2021 third_quarter MED Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; indigenous health center; other extraneous issues as they may arise HOUSE OF REPRESENTATIVES,Natl Science Foundation (NSF),SENATE   40000 0 0 2021-10-19T05:27:59.210000-04:00
2687839 VAN SCOYOC ASSOCIATES 802de3ba-7dda-48cf-8033-d0ae68e9f818 Q3 VAN SCOYOC ASSOCIATES 39837 ARUP LABORATORIES, INC. 2021 third_quarter MED H.R.44128/S.2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, Diagnostic Lab Testing Laboratory Testing related issues Monitor the following: American Jobs Plan Highly skilled visa related issues CURES 2.0, Diagnostic Lab Testing issues Build Back Better Act/Monitor H.R.3684, Infrastructure Investment and Jobs Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-10-19T06:13:08.630000-04:00
2687854 VAN SCOYOC ASSOCIATES b8f2ae53-f0a8-40fa-8060-0101aaa783e6 Q3 VAN SCOYOC ASSOCIATES 39837 MEDICAL COLLEGE OF WISCONSIN 2021 third_quarter MED H.R.4432, Department of Defense Appropriations Act, FY2022, Healthcare research and development related issues H.R.4355/S.2604, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2022, Healthcare research and development related issues Healthcare research and development related issues, as follows: H.R.4505, Commerce, Justice, Science, and Related Agencies Appropriations Act, FY2022 H.R.4502, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022 H.R.4550, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, FY2022 Build Back Better Act, Endowment Tax issues SENATE 30000   0 0 2021-10-19T06:22:11.410000-04:00
2687940 VAN SCOYOC ASSOCIATES efa803da-a28e-445c-b165-3a240559f6b6 3T VAN SCOYOC ASSOCIATES 39837 HUMANIGEN, INC. 2021 third_quarter MED Therapeutics manufacturing, review and authorization issues Supply chain and National Stockpile preparedness related issues H.R.4502, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022 Monitor implementation of Public Law 117-2, American Rescue Plan Act of 2021 HOUSE OF REPRESENTATIVES,SENATE 40000   0 1 2021-10-19T07:44:37.567000-04:00
2688085 CAPITOL DECISIONS, INC. 7155a246-1500-4c4b-b29f-689f0f4554d9 Q3 CAPITOL DECISIONS, INC. 55165 VAN SCOYOC ASSOCIATES (MEDICAL UNIVERSITY HOSPITAL AUTHORITY) 2021 third_quarter MED Monitor the following: Medical research and development related issues National Institutes of Health, and various institutes and bureaus thereof Health Resources Services Administration       0 0 2021-10-19T08:49:14.733000-04:00
2688396 HOOPER, LUNDY & BOOKMAN, P.C. 0971f0e6-2ac3-47e9-950d-04fc3556219b Q3 HOOPER, LUNDY & BOOKMAN, P.C. 401020884 ROCHE DIAGNOSTICS CORPORATION 2021 third_quarter MED The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (HR 4128/S 2209). Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-10-19T09:37:24.560000-04:00
2688460 BOSE PUBLIC AFFAIRS GROUP 0a6ec724-1623-4a34-bdd6-da299f973238 Q3 BOSE PUBLIC AFFAIRS GROUP 297294 AMERICAN ACADEMY OF ANESTHESIOLOGIST ASSISTANTS 2021 third_quarter MED issues related to licensure Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 10000   0 0 2021-10-19T09:42:40.670000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2822.805ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API